A Pilot Trial of RNS60 in Amyotrophic Lateral Sclerosis

INTRODUCTION: RNS60 is a novel immune-modulatory agent that has shown neuroprotective effects in ALS pre-clinical models. RNS60 is administered by weekly intravenous infusion and daily nebulization. The objective of this pilot open-label trial was to test the feasibility, safety, and tolerability of...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Muscle Nerve
Asıl Yazarlar: Paganoni, Sabrina, Alshikho, Mohamad J., Luppino, Sarah, Chan, James, Pothier, Lindsay, Schoenfeld, David, Andres, Patricia L., Babu, Suma, Zürcher, Nicole R., Loggia, Marco L., Barry, Robert L., Luotti, Silvia, Nardo, Giovanni, Trolese, Maria Chiara, Pantalone, Serena, Bendotti, Caterina, Bonetto, Valentina, De Marchi, Fabiola, Rosen, Bruce, Hooker, Jacob, Cudkowicz, Merit, Atassi, Nazem
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2018
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6379136/
https://ncbi.nlm.nih.gov/pubmed/30458059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mus.26385
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller